FBM Industria Brasileira Ltda   Report issue

For profit Phase 3
Founded: Anapolis Brazil (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2018
NCT03281187
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

FBM Industria Brasileira Ltda | FBM Indústria Farmacêutica Ltda.

Active Ingredients

Drugs in Phase 3 Trials (1)

testosterone (delatestryl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypogonadism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1